Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
October 31, 2011 -0.0722M
July 31, 2011 0.0027M
April 30, 2011 -0.0034M
January 31, 2011 0.001M
October 31, 2010 0.0051M
July 31, 2010 -0.0024M
April 30, 2010 0.15M
January 31, 2010 0.0001M
October 31, 2009 -0.0149M
July 31, 2009 -0.084M
April 30, 2009 0.0721M
January 31, 2009 0.0003M
October 31, 2008 -0.0816M
July 31, 2008 -0.0004M
April 30, 2008 -0.0128M
January 31, 2008 -0.0237M
October 31, 2007 0.0078M
July 31, 2007 0.029M
April 30, 2007 0.0005M
January 31, 2007 -0.0816M
October 31, 2006 -0.0214M
July 31, 2006 -0.0558M
April 30, 2006 -0.0924M
January 31, 2006 -0.0331M
October 31, 2005 -0.0559M
Date Value
July 31, 2005 -0.1866M
April 30, 2005 -0.1335M
January 31, 2005 -0.1914M
October 31, 2004 -0.0702M
July 31, 2004 -0.2891M
April 30, 2004 -0.499M
January 31, 2004 -0.3908M
October 31, 2003 0.038M
July 31, 2003 -0.1411M
April 30, 2003 -0.2213M
January 31, 2003 -0.7633M
October 31, 2002 1.093M
July 31, 2002 -0.9192M
April 30, 2002 -0.2997M
January 31, 2002 -0.2515M
October 31, 2001 -0.4215M
July 31, 2001 -0.8168M
April 30, 2001 -0.7705M
January 31, 2001 -1.028M
October 31, 2000 -0.7181M
July 31, 2000 -0.7781M
April 30, 2000 -1.110M
January 31, 2000 -0.736M
October 31, 1999 -0.9239M
July 31, 1999 -0.8826M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. -177.47M
Oncolytics Biotech, Inc. -8.066M
Sangamo Therapeutics, Inc. -19.28M
Sarepta Therapeutics, Inc. 197.07M
Anixa Biosciences, Inc. -1.77M